Table 2.
Performance of Carba 5 assay and Xpert Carba-R assay using isolates from the prospective analysis
| Target carbapenemase | Number of isolates | Carba 5 | Xpert Carba-R | ||
|---|---|---|---|---|---|
| % sensitivity (95% CI) | % specificity (95% CI) | % sensitivity(95% CI) | % specificity (95% CI) | ||
| Class A | |||||
| KPC | 32 | 100 (89.11–100) | 100 (78.20–100) | 100 (89.11–100) | 100 (78.20–100) |
| Class B | |||||
| NDM | 4 | 100 (39.76–100) | 100 (91.78–100) | 100 (39.76–100) | 100 (91.78–100) |
| Class A + B | |||||
| KPC + NDM | 1 | 100 (2.50–100) | 100 (92.29–100) | 100 (2.50–100) | 100 (92.29–100) |
| Overall | 37 | 100 (90.51–100) | 100 (69.15–100) | 100 (90.51–100) | 100 (69.15–100) |
| Non carbapenemase producers | 10 | ||||